Bernt Endrerud
Fortune : 5 M $ au 31/05/2026
Fortune : 5 M $ au 31/05/2026
Bernt Endrerud is currently the Chairman & Managing Director at Care Holding AS, a Director at Hopen Invest AS, and a Director at D'Liver AS.
He previously worked as a Director at Lytix Biopharma AS and Lysnes Invest AS.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Magnora ASA
Magnora ASA Electric UtilitiesUtilities Operates as a renewable energy development company 2,07 % | 31/12/2024 | 1 500 000 ( 2,07 % ) | 5 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Care Holding AS | Directeur Général | 29/07/2009 |
Hopen Invest AS
Hopen Invest AS Financial ConglomeratesFinance Invests in other companies and owns and manages real estate | Directeur/Membre du Conseil | 17/02/2011 |
D'Liver AS
D'Liver AS BiotechnologyHealth Technology Provides laboratory services, products, and consulting within biotechnology and drug development | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| LYTIX BIOPHARMA ASA | Directeur/Membre du Conseil | - |
Lysnes Invest AS
Lysnes Invest AS Financial ConglomeratesFinance Investment company that focuses in owning and managing real estate | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Care Holding AS | |
Lytix Biopharma AS
Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Hopen Invest AS
Hopen Invest AS Financial ConglomeratesFinance Invests in other companies and owns and manages real estate | Finance |
Lysnes Invest AS
Lysnes Invest AS Financial ConglomeratesFinance Investment company that focuses in owning and managing real estate | Finance |
D'Liver AS
D'Liver AS BiotechnologyHealth Technology Provides laboratory services, products, and consulting within biotechnology and drug development | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national